City

Brownsville (1)

Easley (1)

Elkhorn (1)

Forney (1)

Houston (1)

Lahore (1)

Miami (1)

Morgantown (1)

Condition

COVID 19 Disease (2)

Covid 19 Disease (1)

Infectious Disease (1)

Mild to Moderate COVID 19 Disease (1)

SARS-CoV-2 (1)

Severe Acute Respiratory Syndrome Coronavirus 2 (1)

Overall Status

Completed (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 3 (1)

Sponsor

60 Degrees Pharmaceuticals LLC (1)

60P Australia Pty Ltd (1)

Fatima Memorial Hospital (1)

Collaborator

Intervention

placebo (2)

tafenoquine oral tablet (2)

dexamethasone 2 mg/ml (1)

methylprednisolone injection (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

covid 19 disease

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

COVID 19 Disease, Mild to Moderate COVID 19 Disease, SARS-CoV-2 Trial (Tafenoquine Oral Tablet, Placebo)

Not yet recruiting

COVID 19 Disease
+4 more

Tafenoquine Oral Tablet
Placebo

(no location specified)

Jul 13, 2023

COVID 19 Disease Trial in United States (Tafenoquine Oral Tablet, Placebo)

Completed

COVID 19 Disease

Tafenoquine Oral Tablet
Placebo

Miami, Florida
+9 more

Jan 13, 2023

Covid 19 Disease Trial in Lahore (Dexamethasone 2 MG/ML, Methylprednisolone Injection)

Completed

Covid 19 Disease

Dexamethasone 2 MG/ML
Methylprednisolone Injection

Lahore, Punjab, Pakistan

Fatima Memorial Hospital

Oct 24, 2020